Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| MAM-M82E3 | Mouse | Biotinylated Mouse MAdCAM-1 Protein, His,Avitag™ (MALS verified) |  |
|
|
| MAM-C82E3 | Cynomolgus | Biotinylated Cynomolgus MAdCAM-1 Protein, His,Avitag™ (MALS verified) |  |
|
|
| MAM-H52H4 | Human | Human MAdCAM-1 Protein, His Tag (MALS & SPR verified) |  |
|
|
| MAM-H8251 | Human | Biotinylated Human MAdCAM-1 Protein, Fc,Avitag™ (MALS verified) |  |
|
|
| MAM-H5253 | Human | Human MAdCAM-1 Protein, Fc Tag (MALS verified) |  |
|
|
Human MAdCAM-1, His Tag (Cat. No. MAM-H52H4) immobilized on CM5 Chip can bind Human ITGA4&ITGB7 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT7-H52W4) with an affinity constant of 0.227 μM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Vedolizumab | MLN-0002; LPD-02; MLN-002; MLN-02; LDP-02 | Approved | Millennium Pharmaceuticals Inc | Entyvio, Entyvio Pen, Kynteles, 安吉优 | United States | Colitis, Ulcerative; Crohn Disease | Takeda Pharmaceuticals USA Inc | 2014-05-20 | Pediatric ulcerative colitis; Melanoma; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Gastritis; Urogenital Neoplasms; Colitis, Ulcerative; Cholangitis, Sclerosing; Celiac Disease; Solid tumours; Colitis; Neoplasms; Pouchitis; Pediatric Crohn's disease; Inflammatory Bowel Diseases; HIV Infections; Hematopoietic stem cell transplantation (HSCT) | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Ontamalimab | SHP-647; PF-00547659; PF-547659 | Phase 3 Clinical | Pfizer Inc | Ileitis; Colitis, Ulcerative; Crohn Disease | Details |
| Vedolizumab biosimilar (Polpharma Biologics) | PB-016 | Phase 3 Clinical | Polpharma Biologics Sa | Pouchitis; Colitis, Ulcerative; Crohn Disease | Details |
| Vedolizumab biosimilar (Alvotech) | AVT-16; AVT16 | Phase 3 Clinical | Alvotech Swiss Ag | Immune System Diseases; Colitis, Ulcerative | Details |
This web search service is supported by Google Inc.
A-Z
